We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Outcome(s) by the Central Arbitration Committee on an application from USDAW.
Accord Healthcare limited is recalling a single batch due to an out of specification test result.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Check what side effects people have reported when they have taken a medicine.
List of substances recognised as medicinal by function.
Government launches consultation to help combat rising drug deaths from opioids, as part of record £3.4 billion in investment in drug and alcohol services.
A guide to the legislation enabling drug services and others to supply take home naloxone without a prescription to save a life in an emergency.
Batches of quetiapine oral suspension from Eaststone Limited are being recalled due to the active content being twice the amount it should be. Patients should not stop taking this medicine without consulting their healthcare professional.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).